EW News and Press, Edwards Lifesciences Corporation

2024-07-05 15:39:25 ET Summary Edwards Lifesciences Corporation is a top-quality company with strong growth in heart-related products and solid financial performance. The company has shown consistent revenue growth and margin improvement over the years, resulting in premium valuat...

2024-07-03 22:30:00 ET Summary Closing out the first half of 2024, the S&P 500 Total Return Index (which includes dividend reinvestment) is up an incredible +15.3%. According to Apollo asset management, Nvidia accounted for a record-breaking 34.5% of the total return in the S&...

2024-07-02 13:15:22 ET More on S&P 500 Index: Earnings Bar Lowered As Q2 Reports Begin Growth Versus Disinflation Rate Cut By The Fed: Here Is What To Expect For Your Portfolio Citi says the S&P 500 has more upside in H2 and spotlights sectors it pref...

2024-06-25 09:39:09 ET More on iShares MSCI ACWI ETF: ACWI: Go With U.S. Funds Instead ACWI: Balanced Exposure To Global Markets Is Mature, But Reward Looks Unattractive Stocks with the largest market cap in the U.S. from the 1950s to today - MSIM Equities ar...

2024-06-22 04:43:50 ET Summary Investment opportunity in Edwards Lifesciences Corporation. Bullish signs on technical analysis: bouncing off rising 30-week EMA, cup with handle formation, bullish momentum, institutional buying, and improving relative strength. Potential 42% ga...

Vancouver, British Columbia--(Newsfile Corp. - June 19, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") announces that the Board of directors has determined that its in the best interest of the Company to return capital to its shareholders by way of a reduction in st...

2024-06-18 11:06:42 ET More on AtriCure AtriCure, Inc. (ATRC) Q1 2024 Earnings Call Transcript AtriCure Q1 2024 Earnings Preview AtriCure upgraded at Oppenheimer on valuation Seeking Alpha’s Quant Rating on AtriCure Historical earnings data for...

Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve p...

2024-06-05 11:21:33 ET More on iShares U.S. Medical Devices ETF: IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF Don't expect pandemic backlog to fuel orthopedic sales, says Needham Seeking Alpha’s Quant Rating on iShares U....

2024-06-03 15:19:23 ET More on the markets S&P 500 Investor Focus Shifts Forward To Q4 2024 Nasdaq, S&P, and Dow trade mixed while yields slide Tech Sector Revisions Still Positive After Salesforce Last Week Stock volatility may pick up in June after ...